Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · UFP Technologies (UFPT)

UFP Technologies Q1 net sales rise 4.1% to $154.2 million; GAAP EPS $2.24

Positive Impact 3 of 5 earnings Written later

UFP Technologies reported first-quarter 2026 results for the period ended March 31, 2026, with net sales up 4.1% to $154.2 million and net income up 1.8% to $17.5 million. GAAP diluted EPS was $2.24, up from $2.21, while adjusted EPS was $2.48 compared with $2.47 a year earlier. Organic sales were essentially flat, and management said EPS growth lagged revenue growth due to softer results at its AJR operation and start-up costs for four large programs.

Key points

  • Net sales rose 4.1% to $154.2 million, from $148.1 million; organic sales were essentially flat, with 0.4% organic growth per the filing's reconciliation.
  • Net income was $17.5 million versus $17.2 million; GAAP diluted EPS was $2.24 versus $2.21, and adjusted EPS was $2.48 versus $2.47.
  • Non-medical sales fell 15.0% to $10.8 million, while medical sales rose 5.9% to $143.4 million.
  • Management expects four large programs to be significant contributors in the second half of 2026, and a conference call is scheduled for May 5, 2026, at 8:30 AM Eastern time.

The filing

CompanyUFP Technologies (UFPT)
Form8-K, current report
Filed with the SECMay 4, 2026, 4:56 PM ET
Accession number0001628280-26-029906

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 04, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.